Verona, Italy

Francesca Bonetti



Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Francesca Bonetti: Innovator in Pharmaceutical Compounds

Introduction

Francesca Bonetti is a notable inventor based in Verona, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for medical treatments. With a total of 2 patents, her work has the potential to impact various medical conditions.

Latest Patents

Francesca's latest patents include innovative compounds that focus on pharmaceutical compositions and methods for treatment. One of her notable inventions involves compounds of formula (I), which are designed for treating diseases and conditions mediated by the modulation of voltage-gated sodium channels. This advancement showcases her commitment to addressing critical health issues through scientific innovation.

Career Highlights

Throughout her career, Francesca has worked with prominent companies in the pharmaceutical industry. She has been associated with Convergence Pharmaceuticals Limited and Glaxo Group Limited, where she has contributed her expertise in drug development and research. Her experience in these organizations has helped her refine her skills and expand her knowledge in the field.

Collaborations

Francesca has collaborated with esteemed colleagues such as Giuseppe Alvaro and David Amantini. These partnerships have allowed her to enhance her research and contribute to groundbreaking advancements in pharmaceutical science.

Conclusion

Francesca Bonetti stands out as an influential inventor in the pharmaceutical sector. Her innovative patents and collaborations reflect her dedication to improving healthcare through scientific research. Her contributions are poised to make a lasting impact on the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…